| 000 | 01880 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250516154824.0 | ||
| 264 | 0 | _c20150129 | |
| 008 | 201501s 0 0 eng d | ||
| 022 | _a1029-2403 | ||
| 024 | 7 |
_a10.3109/10428194.2013.816423 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWiegering, Verena | |
| 245 | 0 | 0 |
_aImpaired B-cell reconstitution in children after chemotherapy for standard or medium risk acute precursor B-lymphoblastic leukemia. _h[electronic resource] |
| 260 |
_bLeukemia & lymphoma _cApr 2014 |
||
| 300 |
_a870-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aAsparaginase _xtherapeutic use |
| 650 | 0 | 4 |
_aB-Cell Activating Factor _xmetabolism |
| 650 | 0 | 4 |
_aB-Lymphocyte Subsets _ximmunology |
| 650 | 0 | 4 |
_aBiomarkers _xmetabolism |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aDaunorubicin _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunophenotyping |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aKiller Cells, Natural _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPrecursor B-Cell Lymphoblastic Leukemia-Lymphoma _xdrug therapy |
| 650 | 0 | 4 |
_aPrednisone _xtherapeutic use |
| 650 | 0 | 4 |
_aT-Lymphocyte Subsets _ximmunology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVincristine _xtherapeutic use |
| 700 | 1 | _aFrank, Jana | |
| 700 | 1 | _aFreudenberg, Sandra | |
| 700 | 1 | _aMorbach, Henner | |
| 700 | 1 | _aSchlegel, Paul G | |
| 700 | 1 | _aEyrich, Matthias | |
| 700 | 1 | _aWinkler, Beate | |
| 773 | 0 |
_tLeukemia & lymphoma _gvol. 55 _gno. 4 _gp. 870-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/10428194.2013.816423 _zAvailable from publisher's website |
| 999 |
_c22852753 _d22852753 |
||